OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-12-31-accounts

Charity registration number 1157579 (England and Wales)

Charity registration number SC050752 (Scotland) Company registration number 09044459

OVERCOMING MULTIPLE SCLEROSIS

ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

1

OVERCOMING MULTIPLE SCLEROSIS LEGAL AND ADMINISTRATIVE INFORMATION

Trustees L M Bloom
M L Sugarman
P Hanson
S M Middlemiss
S Saraf (Appointed 5 January 2024)
K C Bayles (Appointed 5 January 2024)
P Harris (Appointed 14 May 2024)
K Carpenter (Appointed 14 May 2024)
Charity number 1157579
(England and Wales)
Charity number SC050752
(Scotland)
Company number 09044459
Registered office c/o Gravita Oxford LLP
First Floor, Park Central
40-41 Park End Street
Oxford
OX1 1JD
Auditor c/o Gravita Oxford LLP
First Floor, Park Central
40-41 Park End Street
Oxford
OX1 1JD
Bankers Virgin Money UK PLC
177 Bothwell Street
Glasgow
G2 7ER

2

OVERCOMING MULTIPLE SCLEROSIS CONTENTS

Page
Introduction - Strengthening our commitment 4
Trustees report 5 -17
•
Objectives and activities
•
Achievements and performance
•
Income generation
•
Financial review
•
Plans for future periods
•
Structure, governance and management
Statement of Trustees responsibilities 18
Independent auditor's report 19 - 22
Statement of financial activities 23
Balance sheet 24
Statement of cash flows 25
Notes to the financial statements 26 - 35

3

OVERCOMING MULTIPLE SCLEROSIS INTRODUCTION – STRENGTHENING OUR COMMITMENT

Stepping in as interim Chair for Overcoming MS is a true privilege and I’m proud to say that in 2024, we reached significant milestones. Our flagship lifestyle courses, life-changing residential Retreats and our Pathways courses delivered real and measurable results, as presented at the British Society of Lifestyle Medicine (BSLM) and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conferences. This year we have focused on developing externally recognised globally-validated measures to measure the impact of our work.

Knowing that attendees on our Pathways courses reported a 34% improvement in overall measures (wellbeing, confidence to follow the Program, ability to talk with family/friends), and that 89% of attendees would recommend Pathways, puts us in a strong position moving forward.

The Live Well Hub, a global platform for people with MS interested in lifestyle continued to grow, fostering connections between people from around the world, and our website supported 390,000 people during the year.

I would like to extend my deepest gratitude to everyone who makes our work possible. To our individual donors, fundraisers, trusts and corporate supporters - without you, our work would not be possible. To our passionate community, our volunteers, partners and collaborators, staff, and Board members – thank you for your dedication and passion. Through our combined efforts, more people can live well with MS.

Penny Harris Interim Chair of the Board of Trustees, Overcoming MS

Date: 25[th] July 2025

4

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

The Trustees (who are also directors of the charity for the purposes of the Companies Act) present their annual report together with the financial statements of Overcoming Multiple Sclerosis (the company) for the year ended 31 December 2024.

The Trustees confirm that the Annual Report and financial statements of the company comply with the current statutory requirements, the requirements of the company's governing document and the provisions of the Statement of Recommended Practice (SORP), applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Ireland (FRS 102) (effective 1 January 2019).

Since the company qualifies as small under section 383, the strategic report required of medium and large companies under The Companies Act 2006 (Strategic Report and Director's Report) Regulations 2013 is not required.

The Trustees are responsible for the maintenance and integrity of the corporate and financial information including that is published on the charity’s website.

OBJECTIVES AND ACTIVITIES

Overcoming MS – bringing hope

Overcoming MS is here to enable everyone with multiple sclerosis (MS) to achieve optimal health and wellbeing through making informed healthy lifestyle choices.

As a world-leading multiple sclerosis healthy lifestyle charity, we help people discover hope, learn about lifestyle, connect with the community, change lifestyle habits and live well for life.

What is MS?

Every five minutes, someone, somewhere in the world is told that they have multiple sclerosis. MS is a neurological condition that affects the central nervous system and causes a range of life-altering symptoms, which are different for everyone, making it difficult to manage. These include problems with balance, vision, extreme fatigue, pain, muscle spasms, problems with thinking and memory, as well as bowel and bladder issues and many more.

Helping people live well with MS

The impact of an MS diagnosis

Being diagnosed with MS can be devastating; in just seconds, the future that you saw for yourself and your loved ones has been shattered. A diagnosis often comes in the prime of your life, when you should be planning your future with confidence, not facing a lifetime of fear and uncertainty. Knowing you have MS can feel incredibly isolating and lonely.

As there is currently no cure for MS, at the point of diagnosis, hope is often lost, being replaced by fear of the unknown. Overcoming MS is here to restore that hope. There is

5

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

substantial scientific evidence that lifestyle choices, alongside medication, benefit physical and mental health. A high quality diet, such as that recommended as part of the Overcoming MS Program, has been shown to reduce disability progression in people with MS by as much as 50% over 7 ½ years[1] .

Our support: helping people live well with MS

Overcoming MS is here to enable everyone with MS to achieve optimal health and wellbeing through making informed healthy lifestyle choices. We empower people with MS to take control of their health and wellbeing and:

Having MS is life-altering, but a full and healthy life with MS is possible

The Overcoming MS Program

The Overcoming MS Program, following comprehensive research, is at the centre of our work. The Program covers medication, diet, vitamin D, physical activity, stress management, family health (reducing risk for family members) and changing your life, for life (ensuring permanent lifestyle changes). Research shows that people engaging in four or more healthy lifestyle behaviours had more clinically significant positive outcomes than those engaging in just one or two. These outcomes included a higher mental and physical quality of life, lower fatigue levels, and less disability[2] .

1 Simpson-Yap S, Neate SL, Nag N, Probst YC, Yu M, Jelinek GA, Reece JC: Longitudinal associations between quality of diet and disability over 7.5 years in an international sample of people with multiple sclerosis. Eur J Neurol 2023, 30:3200-3211.

2 Yu M, Neate S, Nag N, Bevens W, Jelinek G, Simpson-Yap S, Davenport RA, Fidao A, Reece J. Baseline engagement with healthy lifestyles and their associations with health outcomes in people with multiple sclerosis enrolled in an online multimodal lifestyle course. Eur J Neurol. 2024 Aug

7:e16429. doi: 10.1111/ene.16429. Epub ahead of print. PMID: 39109838. Accessed Jan 2025

6

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

ACHIEVEMENTS AND PERFORMANCE: Giving hope through learning the impact of lifestyle on MS

Challenge:

When diagnosed with MS, people face a future of fear and uncertainty. They feel isolated, overwhelmed and without hope. People with MS must navigate complex and conflicting information on their own, as health professionals globally are stretched and often lack awareness of the benefits of lifestyle changes for people with MS. Many are simply unaware that making informed lifestyle choices would positively impact their quality of life – both now and in the future.

2024 actions:

Our website, social media, YouTube channels and digital advertising played a vital role in extending our global impact. Through engaging content and interactive platforms, we connected with people worldwide, particularly in the US, UK, Australia, and Canada. By expanding our digital presence, we offered more people hope and guidance on lifestyle choices that support living well with MS.

Our free-to-attend Pop-Up Tour reached more people so they could connect in-person and thrive in small group settings. Across the UK, including Manchester, Belfast, and Hampshire, attendees engaged with expert voices and explored practical tools—from nutrition to stress management—to help them live well with MS.

“My favourite part of the Pop-Up was the opportunity to meet others facing similar challenges. This was invaluable.” - Pop-Up attendee 2024

Our Living Well with MS webinar and podcast series features global experts covering the Overcoming MS pillars, with webinars giving live attendees the opportunity to ask questions directly. Presenters included neurologist Dr Aaron Boster, Dr Michelle

7

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

O’Donoghue from Harvard Medical School, Dr Phil Startin on stress management, plantbased chef Jack McNulty, and Dr Rob Motl from the University of Illinois.

“Overcoming MS gives me hope and freedom, and I am convinced, after watching this webinar, that you can live a much fuller life with MS.” – 2024 Webinar Attendee

We have stepped up our activity in 2024 by attending conferences and events to raise awareness of Overcoming MS with healthcare professionals. Approximately 15,000 people attended healthcare events where we had a presence, including ECTRIMS, the largest international conference covering research and care in MS.

Outcome:

Through our activities, people with MS discovered hope, becoming aware that lifestyle choices can help them live well with MS. Our accessible, evidence-based resources and events gave people the information they need to make informed decisions, and the discovery of a like-minded community inspired people to take action.

ACHIEVEMENTS AND PERFORMANCE: Connecting to like-minded community members

Challenge:

Having a diagnosis of MS can be incredibly isolating and lonely. Managing MS can, in itself, be overwhelming, especially when navigating new routines and treatments. The uncertainty of the future can be incredibly daunting. The benefit of lifestyle change brings hope, but it can be difficult to implement these changes alone. Sometimes you just need to be with people who ‘get it’, people who understand, share tips and advice and help face a future with positivity.

2024 actions:

The Live Well Hub, our app and digital platform that enables people to connect to a supportive, like-minded community, doubled its reach by the end of 2024, attracting members from around the world. The Hub offers a positive space for sharing tips, ideas, and experiences about lifestyle changes and MS. Livestreams, new content and courses drove engagement, including the Jelinek Journals, where Professor Jelinek shared his post-diagnosis experiences.

8

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

Our Circles offer small, peer-to-peer support groups led by volunteer Ambassadors — people with MS dedicated to helping others. Individuals connect, share, and support one another, fostering close, meaningful connections. Groups form around geographic locations or shared interests, such as family support, progressive MS, or healthcare professionals living with MS, and help individuals feel less isolated and more empowered.

“Overcoming MS has been so helpful for me, as someone who was newly diagnosed this year. It’s wonderful to be able to connect with so many people all over the world and their enthusiasm gives me so much optimism for the future!” – Circle Member

Our dedicated volunteers are essential to our work. While Ambassadors lead Circles, others support initiatives like the Communications Advisory Group, trusteeship, video editing, webinar panels, and podcast hosting. Volunteers also played key roles in local events like the Manchester Mindfulness event and the Hampshire Pop-Up and contributed to strategic projects like the NHS mapping project in Manchester. Their voices strengthened advocacy efforts during MS Awareness Week and inspired others through webinar panels and campaigns.

“I look for opportunities to use my skills to help, like in my Ambassador role… I am so grateful I found you.” – Ambassador

Outcome:

Our supportive community plays a crucial role in helping individuals feel less alone, more empowered, and better equipped to make and sustain lifestyle choices that impact their quality of life. Individuals in the community share, learn, and inspire one another, fostering belonging and optimism, and overcoming challenges.

ACHIEVEMENTS AND PERFORMANCE: Making lifestyle change happen

Challenge:

People with MS can struggle to make lifestyle changes, even when they understand the

9

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

benefits. But making and maintaining these changes can be difficult without the right tools and encouragement, particularly alongside work, family life, and whilst managing the impact of symptoms or progressive disability. Shifting long-held habits and adapting to new routines while managing the emotional impact of MS can be overwhelming.

2024 actions:

Launched in January 2024, the 6 Months to Overcoming MS course offers flexible, selfpaced learning through the Live Well Hub. Participants can focus on specific pillars of diet, vitamin D, physical activity, or stress management—or follow the complete Overcoming MS Program. Designed by expert facilitators and tested by the community, it offers step-by-step guidance for adopting healthy habits that last.

o 1,087 members signed up during 2024

“It’s deceptive in its simplicity because it gives you all the tools.” 6 months to Overcoming MS participant

The Pathway to Overcoming MS course is an 8-week online programme that helps people deepen their understanding of lifestyle choices and self-management for MS. Co-designed with people living with MS, it takes a holistic approach, covering nutrition, medication, physical activity, stress management, and behaviour change. Led by experts with lived experience of MS, the course offers expert teaching, group consultations and peer support.

“I wanted all the tools to take control of my health, and this course helped me fill my toolbox to live my best life.”

Our residential Retreats combine six weeks of online preparation with a three-day inperson Retreat. Facilitated by experts with lived MS experience, the Retreats offer an in-depth, supportive environment to help participants make long-term lifestyle changes. In 2024, our impact was recognised by the British Society of Lifestyle Medicine (BSLM) Conference, where our abstract “Hybrid Retreat Model Supports Health Improvement in Multiple Sclerosis” was accepted for poster presentation.

10

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

“A life-changing experience. The power of connection, of belonging, being seen… Not just transformative for knowledge, but also the way we live.” – Ellen, Retreat participant 2024

Outcome:

Through structured courses, Retreats, and flexible self-paced learning, people with MS gained the tools, knowledge, and confidence to make lasting lifestyle changes. Our approach supported individuals in adopting healthy habits that improve their quality of life, with the flexibility to choose the format and lifestyle changes that best suit their needs.

ACHIEVEMENTS AND PERFORMANCE: Developing our expertise and impact

Expanding knowledge and expertise is fundamental to improving the lives of people with MS. Education provides individuals with the confidence and tools to make informed lifestyle choices, enhancing both mental and physical well-being. By strengthening our expert network and collaborating with healthcare professionals and partners, we ensure that evidence-based approaches to MS management are widely understood and accessible. Through local service support and professional education, we are not only empowering individuals but also shaping the future of MS care. Increasing expertise at every level—from those living with MS to healthcare providers—enhances the effectiveness and reach of the Overcoming MS Program, creating lasting change .

Impact on people with MS

We revisited the impact measurement of our support services, implementing externally recognised validated questions, enabling us to demonstrate real impact. Reports from six cohorts of our courses using self-reported measures showed positive, measurable outcomes: 

  - 36% increase in both mental and physical wellbeing, demonstrating the value of practical education in a supportive space

  - 44% increase in confidence to understand and act on lifestyle guidance

  - 38% increase in confidence to discuss lifestyle with family and friends.

11

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

“Training as a Facilitator is important to me because it’s an opportunity to give something back to the Overcoming MS community and charity because the Program has transformed my life in so many positive ways.” Yas Neves

Impact on healthcare professionals

To support healthcare education, we:

Impact through partnerships

12

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

INCOME GENERATION

None of the transformational work described on the preceding pages would be possible without the generosity of our incredible supporters. From soapbox races to skydives, birthday fundraisers to bake sales, our brilliant community continues to amaze and astound us with their ingenuity, dedication and indefatigability. We’re also hugely grateful to the trusts, foundations and corporate partners who support our work and all those wonderful individuals who contribute through major gifts, regular gifts, legacy pledges, gifts in memory and responses to our appeals. Their continuing commitment enables all that we do to help people with MS to live well.

In 2024, we were delighted to maintain our high level of direct investment in our charitable activities, with 76p in every £1 spent going on the products and services we offer to our community. Likewise, our own fundraising team delivered a highly effective fundraising operation, with £5 raised for every £1 spent on fundraising activities.

Our total income was £1,204,379 fundraised from donations, community, grants and through pro-bono services. In 2023 our total income was £1,016,960

As a small charity, we will continue to work hard with our funders and supporters to expand our programme of support and help more people with MS live a full and healthy life.

We are grateful to all our funders, our individual fundraisers and everyone who has supported us. We would like to thank the National Lottery Community Fund and The 29[th] May 1961 Charitable Trust for their support and The Bloom Foundation for their ongoing contribution. We have made a strategic commitment to reducing our dependence on The Bloom Foundation as our core funder over the next few years and to diversifying our income generation through a balanced portfolio of different income streams, which has already begun to bear fruit.

Expenditure

Our total expenditure in 2024 was £983,038 and in 2023 was £1,049,439. Over 50% of our expenditure was spent on delivering and expanding our program of support.

Gifts-in-kind

We received gift-in-kind design and brand support from JMA Creative to the value of £7,745. We also received £87,658 from the Google Grant, and pro bono HR/legal support and staff training with estimated values of £20,000 and £6,309 respectively.

13

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

FINANCIAL REVIEW

a. Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing these financial statements. Further details regarding the adoption of the going concern basis can be found in the Accounting Policies .

b. Principal funding

During the year, income was received from three main sources: donations, grants, and events.

The financial statements depart from accounting standards and the Charities SORP (FRS102) in that the first tranche of the 2024 grant from The Bloom Foundation provided under a funding agreement dated 15th December 2023 is recognised as income in the year to give a true and fair view.

The charity is regulated by the Fundraising Regulator and adheres to the Fundraising Code of Practice. There has been no failure to comply with the scheme and no complaints were received either directly or indirectly through any party in 2024.

c. Reserves policy

The reserves policy requires that unrestricted reserves of not less than three months' total costs be maintained to meet the charity’s commitments at any time. The Trustees consider that the charity's reserves are consistent with this policy.

At the end of 2024, the charity held total reserves of £505,962 (2023: £284,622) comprising:

Unrestricted: £ 405,684 (2023: £ 278,303) Designated: £ 80,000 (2023: 0) Restricted: £ 20,278 (2023: £ 6,319)

d. Energy consumption

The Trustees consider there is no requirement for any disclosure pursuant to SI2018/1155 as the charity’s energy consumption is minimal.

14

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

PLANS FOR FUTURE PERIODS

We have worked with our community to establish our focus for 2024 - 2026.

15

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT

The charity is a company limited by guarantee.

The Trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:

A G Bloom (Resigned 10 June 2024) L M Bloom A D Humzah (Resigned 25 November 2024) M L Sugarman P Hanson S M Middlemiss O A Ilenda (Appointed 5 January, resigned 25 November 2024) S Saraf (Appointed 5 January 2024) K C Bayles (Appointed 5 January 2024) P Harris (Appointed 14 May 2024) K Carpenter (Appointed 14 May 2024)

The charity continues to expand its Board of Trustees; four new Trustees joined in 2024. Due to the resignation of our Chair at the end of his term, we are recruiting a new Chair during 2025. Trustees are provided with Charity Commission and other guidance as to their duties and responsibilities both during and after recruitment.

a) Constitution

The charity is registered as a company limited by guarantee and is constituted under a Memorandum of Association dated 14 May 2014. It is a registered with the Charity Commission for England and Wales, number 1157579 and with the Office of the Scottish Charity Regulator, number SC050752.

In 2014, the company took over activities from a predecessor charitable trust, also named Overcoming Multiple Sclerosis. The principal objective of the company is to provide relief to people diagnosed with multiple sclerosis.

b) Method of appointment or election of trustees

The management of the company is the responsibility of the Trustees who are elected and co-opted under the terms of the Articles of Association.

c) Risk management

The Trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud, error, and the consequences of providing healthcare-related information. The charity has put in place a robust risk management framework and a corporate risk register that enables the identification, management, and monitoring of risk at operational and strategic levels. At every meeting, the Board of Trustees scrutinises risks that Overcoming MS faces.

16

OVERCOMING MULTIPLE SCLEROSIS TRUSTEES REPORT (INCLUDING DIRECTORS REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

In the opinion of the Trustees, a key material risk facing the charity is the challenging global fundraising environment due to post-pandemic adjustment, as well as implications from the war in Ukraine and UK economic crisis, which may delay achieving financial sustainability. We have revisited the fundraising strategy and appointed a new Head of Income Generation to help mitigate this risk.

d) Organisational structure and decision making

Regular formal meetings of the Board of Trustees take place to provide support and guidance to the Chief Executive, who is employed to manage the operational activities of the charity. The Trustees maintain oversight of governance, costs and management and approve all strategic plans for the development of the charity.

The Trustees have delegated the day-to-day management of the charity to its Chief Executive Officer, Alex Holden who joined the charity in March 2023, and the Senior Leadership Team.

In the US and Australia, the charity has established independent charitable entities. The CEO of Overcoming MS is a Director of these respective charitable entities, alongside local Directors in both countries. All charitable entities are aligned with the same authorised purposes and charitable goals.

e) Public benefit

The Trustees confirm that they have complied with the duty in Section 4 Part 1 of the Charities Act 2006 to have due regard to public benefit guidance published by the Charity Commission in determining the activities undertaken by the charity.

Auditor

In accordance with the company’s articles, a resolution proposing that Gravita Audit Oxford LLP be reappointed as auditor of the company will be put at a General Meeting.

Disclosure of information to auditor

Each of the Trustees has confirmed that there is no information of which they are aware which is relevant to the audit, but of which the auditor is unaware. They have further confirmed that they have taken appropriate steps to identify such relevant information and to establish that the auditor is ware of such information.

The Trustees report was approved by the Board of Trustees.

…………………………….

Suruchi Saraf FCCA, MSc, DChA Treasurer

Date:25[th] July 2025

17

OVERCOMING MULTIPLE SCLEROSIS STATEMENT OF TRUSTEES RESPONSIBILITIES

The Trustees, who are also the directors of Overcoming Multiple Sclerosis for the purpose of company law, are responsible for preparing the Trustees Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company Law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year.

In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006, the Charities and Trustee Investment (Scotland) Act 2005 and the Charities Accounts (Scotland) Regulations 2006 (as amended). They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report was approved by the Trustees, on 25[th] July 2025 and signed on their behalf by:

Suruchi Saraf FCCA, MSc, DChA Treasurer, Overcoming MS

18

OVERCOMING MULTIPLE SCLEROSIS INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS AND TRUSTEES

Opinion

We have audited the financial statements of Overcoming Multiple Sclerosis (the charitable company) for the year ended 31 December 2024 which comprise the statement of financial activities, the balance sheet, the statement of cash flows and the notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Trustees use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable companies ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The Trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

19

OVERCOMING MULTIPLE SCLEROSIS INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS AND TRUSTEES

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the charity and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report included within the Trustees report.

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors’ report included within the trustees’ report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 and the Charities Accounts (Scotland) Regulations 2006 require us to report to you if, in our opinion:

Responsibilities of Trustees

As explained more fully in the Statement of Trustees responsibilities, the Trustees, who are also the directors of the charitable company for the purpose of company law, are responsible for the preparation of the financial statements and for being satisfied that they

20

OVERCOMING MULTIPLE SCLEROSIS INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS AND TRUSTEES

give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the Trustees are responsible for assessing the charitable companies ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

We have been appointed as auditor under section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005 and under the Companies Act 2006 and report in accordance with the Acts and relevant regulations made or having an effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an

audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

To address the risk of fraud through management bias and override of controls, we:

21

OVERCOMING MULTIPLE SCLEROSIS INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS AND TRUSTEES

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006, and to the charitable company’s trustees, as a body, in accordance with Regulation 10 of the Charities Accounts (Scotland) Regulations 2006. Our audit work has been undertaken so that we might state to the charitable company’s members and trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company, the charitable company’s members as a body and the charitable company’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Katherine Wilkes (Senior Statutory Auditor) For and on behalf of Gravita Audit Oxford LLP, Statutory Auditor Chartered Accountants First Floor, Park Central 40-41 Park End Street Oxford OX1 1JD Date:…………………… 22/8/25

22

OVERCOMING MULTIPLE SCLEROSIS

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2024

Unrestricted
funds
general
Unrestricted
funds
designated
reserves
Restricted
funds
2024
2024
2024
Notes
£
£
£
Income and endowments from:
Donations and legacies
3
1,125,555
-
49,575
Investments
4
4,510
-
-
Other income
5
24,738
-
-
Total income
1,154,803
-
49,575
Expenditure on:
Raising funds
6
245,974
-
-
Charitable activities
7
701,894
-
35,170
Total expenditure
947,868
-
35,170
Net income/(expenditure)
206,935
-
14,405
Transfers between funds
(79,554)
80,000
(446)
Net movement in funds
9
127,381
80,000
13,959
Reconciliation of funds:
Fund balances at 1 January 2024
278,303
-
6,319
Fund balances at 31 December 2024
405,684
80,000
20,278		 Total
Restated
unrestricted
funds
general
Restricted
funds
Restated
Total
2024
2023
2023
2023
£
£
£
£
1,175,130
974,266
11,400
985,666
4,150
3,015
-
3,015
24,738
28,279
-
28,279
1,204,378
1,005,560
11,400
1,016,960
245,974
232,328
-
232,328
737,064
799,030
18,081
817,111
983,038
1,031,358
18,081
1,049,439
221,340
(25,798)
(6,681)
(32,479)
-
6,741
(6,741)
-
221,340
(19,057)
(13,422)
(32,479)
284,622
297,360
19,741
317,101
505,962
278,303
6,319
284,622		 Total
Restated
unrestricted
funds
general
Restricted
funds
Restated
Total
2024
2023
2023
2023
£
£
£
£
1,175,130
974,266
11,400
985,666
4,150
3,015
-
3,015
24,738
28,279
-
28,279
1,204,378
1,005,560
11,400
1,016,960
245,974
232,328
-
232,328
737,064
799,030
18,081
817,111
983,038
1,031,358
18,081
1,049,439
221,340
(25,798)
(6,681)
(32,479)
-
6,741
(6,741)
-
221,340
(19,057)
(13,422)
(32,479)
284,622
297,360
19,741
317,101
505,962
278,303
6,319
284,622
1,016,960
232,328
817,111
1,049,439
(32,479)
-
(32,479)
317,101
284,622

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

The prior year expenditure on raising funds and charitable activities has been restated in order to remain consistent with the current year policy of allocating support costs against fundraising based on staff time on these activities. The net effect on the SoFA is £Nil.

23

OVERCOMING MULTIPLE SCLEROSIS BALANCE SHEET AS AT 31 DECEMBER 2024

Notes
Fixed assets
Intangible assets
13
Tangible assets
14
Current assets
Debtors
15
Cash at bank and in hand
Creditors: amounts falling due
within one year
16
Net current assets
Total assets less current liabilities
The funds of the charity
Restricted income funds
20
Unrestricted funds – general
Unrestricted funds – designated
reserves
19		 2024
£
£
34,642
10,101
44,743
69,487
446,382
515,869
(54,650)
461,219
505,962
20,278
405,684
80,000
505,962		 2023
£
£
11,100
12,523
23,623
27,061
300,189
327,250
(66,251)
260,999
284,622
6,319
278,303
-
284,622		 2023
£
£
11,100
12,523
23,623
27,061
300,189
327,250
(66,251)
260,999
284,622
6,319
278,303
-
284,622
23,623
260,999
284,622
6,319
278,303
-
284,622

The financial statements were approved by the Trustees on 25[th] July 2025.

………………………………….

S Saraf FCCA, MSc, DChA Treasurer

Company registration number 09044459 (England and Wales)

24

OVERCOMING MULTIPLE SCLEROSIS STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2024

Notes
Cash flows from operating activities
Cash generated from operations
24
Investing activities
Purchase of intangible assets
Purchase of tangible fixed assets
Investment income received
Net cash used in investing activities
Net cash generated from financing
activities
Net increase in cash and cash
equivalents
Cash and cash equivalents at
beginning of year
Case and cash equivalents at end of
year		 2024
£
£
171,593
(29,112)
(798)
4,510
(25,400)
-
146,193
300,189
446,382		 2023
£
£
78,269
(11,100)
(5,372)
3,015
(13,457)
-
64,812
235,377
300,189		 2023
£
£
78,269
(11,100)
(5,372)
3,015
(13,457)
-
64,812
235,377
300,189
64,812
235,377
300,189

25

OVERCOMING MULTIPLE SCLEROSIS NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

1. Accounting policies

Charity information

Overcoming Multiple Sclerosis is a charitable company limited by guarantee incorporated in England and Wales. The registered office is c/o Gravita Oxford LLP, First Floor, Park Central, 40-41 Park End Street, Oxford, OX1 1JD.

1.1. Accounting convention

The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006, the Charities and Trustee Investment (Scotland) Act 2005, the Charities Accounts (Scotland) Regulations 2006, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)". The Charity is a Public Benefit Entity as defined by FRS 102.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2. Going concern

At the time of approving the financial statements, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the Trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3. Charitable funds

Unrestricted funds are available for use at the discretion of the Trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4. Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

1.5. Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated in full to support costs.

1.6. Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at

26

OVERCOMING MULTIPLE SCLEROSIS NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Website & CRM Integration

4 year straight line method

1.7. Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers 25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.8. Impairment of fixed assets

At each reporting end date, the Charity reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.9. Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10. Financial instruments

The Charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Charity's balance sheet when the Charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

27

OVERCOMING MULTIPLE SCLEROSIS NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Charity’s contractual obligations expire or are discharged or cancelled.

1.11. Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the Charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12. Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2. Critical accounting estimates and judgements

In the application of the Charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources, appropriate levels of depreciation being based on the assets estimated useful life, amounts to accrue for the year including deferred income and amounts to include as prepayments. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The specific judgements/estimates relate to appropriate levels of depreciation being based on the assets estimated useful life, amounts to accrue for the year including deferred income and amounts to include as prepayments.

3. Income from donations and legacies

Donations and
gifts
Grants		 Unrestricted
funds
2024
£
413,765
711,820
1,125,555		 Restricted
funds
2024
£
-
49,575
49,575		 Total
2024
£
413,735
761,395
1,175,130		 Unrestricted
funds
2023
£
216,266
758,000
974,266		 Restricted
funds
2023
£
-
11,400
11,400		 Total
2023
£
216,266
769,400
985,666

4. Income from investments

Interest receivable

Unrestricted Unrestricted funds funds 2024 2023 £ £ 4,510 3,015

28

OVERCOMING MULTIPLE SCLEROSIS NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

5. Other income

ther income
Unrestricted Unrestricte
funds d funds
2024 2023
£ £
Client events 24,703 27,712
Book royalties 35 567
24,738 28,279
xpenditure on raising funds
Restated
Unrestricted Unrestricte
funds d funds
2024 2023
Fundraising and publicity £ £
Other fundraising costs 23,481 38,482
Staff costs 122,862 85,349
Support costs 99,631 108,497
245,974 232,328

6. Expenditure on raising funds

Total restricted income included in the above is £nil (2023: £nil)

The prior year expenditure on support costs for raising funds has been restated in order to remain consistent with the current year policy of allocating support costs against fundraising based on staff time on these activities. The change is an increase of £108,497.

7. Expenditure on charitable activities

xpenditure on charitable activities
Charitable Charitable
expenditure expenditure
2024 2023
£ £
Direct costs
Staff costs 305,743 290,127
Digital technology investment 37,373 131,370
Other donor related activities 149,287 130,246
Contractors and consultancy 6,503 12,726
498,906 564,469
Share of support and governance costs (see note 8) Restated
Support 229,938 240,512
Governance 8,220 12,130
737,064 817,111
Analysis by fund
Unrestricted funds - general 701,894 799,030
Restricted funds 35,170 18,081
737,064 817,111

29

OVERCOMING MULTIPLE SCLEROSIS NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

The prior year expenditure on support costs for raising funds has been restated in order to remain consistent with the current year policy of allocating support costs against fundraising based on staff time on these activities. The change is a decrease of £108,497.

8. Support costs allocated to activities

upport costs allocated to activities
Staff costs
Depreciation
Website and publicity costs
Internet and IT costs
Bank and credit card charges
Printing, postage and
stationary
Subscriptions
Professional fees
Rent and rates
Travel costs
Office expenses
Exchange (gain)/loss
Governance costs
Analysed between:
Fundraising
Charitable expenditure		 2024
£
72,359
8,790
31,636
80,634
1,506
2,315
2,108
63,915
5,616
25,191
35,499
-
8,220
337,789
99,631
238,158
337,789		 2023
£
92,487
3,556
40,420
68,313
1,506
2,548
1,521
50,593
6,261
27,933
48,402
5,469
12,130
361,139
Restated
108,497
252,642
361,139

The prior year expenditure on support costs for raising funds has been restated in order to remain consistent with the current year policy of allocating support costs against fundraising based on staff time on these activities. The net change is £Nil.

9. Net movement in funds

et movement in funds
2024 2023
£ £
The net movement in funds is stated after
charging/(crediting):
Fees payable for the audit of the charity's financial
statements		 8,220 12,130
Depreciation of owned tangible fixed assets 3,220 3,556
Amortisation of intangible assets 5,570 -
  1. Trustees

30

OVERCOMING MULTIPLE SCLEROSIS NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

None of the Trustees (or any persons connected with them) received any remuneration or benefits from the Charity during the year.

Five trustees (2023: two) received expenses totalling £1,380 (2023: £325) during the year for travel.

11. Employees

The average monthly number of employees during the year was:

he average monthly number of employees during the year was:
Employment costs
Wages and salaries
Social security costs
Other pension costs		 2024
Number
13
2024
£
447,701
47,382
8,881
500,964		 2023
Number
12
2023
£
422,588
36,533
8,842
467,963

The number of employees whose annual remuneration was more than £60,000 is as follows:

2024 2023
Number Number
In the band £60,001 - £70,000 - 1
In the band £80,001 - £90,000 1 -

Remuneration of key management personnel

The remuneration of key management personnel during the year was £92,244 (2023: £65,285)

2024 2023
£ £
Aggregate compensation 92,244 65,285

12. Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

13. Intangible fixed assets

tangible fixed assets
Cost
At 1 January 2024
Additions - internally developed
At 31 December 2024
Amortisation and impairment
At 1 January 2024
Amortisation charged for the year
At 31 December 2024
Carrying amount
At 31 December 2024		 Website &
CRM
Integration
£
11,100
29,112
40,212
-
5,570
5,570
34,642

31

OVERCOMING MULTIPLE SCLEROSIS NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

At 31 December 2023
14. Tangible fixed assets
Cost
At 1 January 2024
Additions
At 31 December 2024
Depreciation and impairment
At 1 January 2024
Depreciation charged in the year
At 31 December 2024
Carrying amount
At 31 December 2024
At 31 December 2023
15. Debtors
Amounts falling due within one year:
Other debtors
Prepayments and accrued income
16. Creditors: amounts falling due within one year
Notes
Other taxation and social security
Deferred income
17
Other creditors
Accruals
17. Deferred income
Other deferred income		 2024
£
25,747
43,740
69,487
2024
£
10,301
22,349
3,497
18,503
54,650
2024
£
22,349		 11,100
Computers
£
19,661
798
20,459
7,138
3,220
10,358
10,101
12,523
2023
£
17,400
9,661
27,061
2023
£
12,059
1,338
1,855
50,999
66,251
2023
£
1,338

Income has been deferred where attendees have paid fees for events that occur in future periods.

32

OVERCOMING MULTIPLE SCLEROSIS NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

Deferred income is included in the financial statements as follows:

eferred income is included in the financial statements as follows:
Deferred income is included within:
Current liabilities
Movements in the year:
Deferred income at 1 January 2024
Released from previous periods
Resources deferred in the year
Deferred income at 31 December 2024		 2024
£
22,349
1,338
(1,338)
22,349
22,349		 2023
£
1,338
2,654
(2,654)
1,338
1,338
18. Retirement benefit schemes
2024 2023
Defined contribution schemes £ £
Charge to profit or loss in respect of defined contribution
schemes		 8,881 8,842

The Charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the Charity in an independently administered fund.

19. Unrestricted funds – designated reserves

These are unrestricted funds which are material to the Charity's activities.

hese are unrestricted funds which are material to the Charity's activities.
One day lifestyle event
Community survey
Audience insight
Website references
Research fund
Retreats research and testing
Major donor prospecting		 At 1
January
2024
-
-
-
-
-
-
-
-		 Transfers
At 31
December
2024
£
£
20,000
20,000
5,000
5,000
10,000
10,000
15,000
15,000
10,000
10,000
10,000
10,000
10,000
10,000
80,000
80,000
80,000

20. Restricted funds

The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used.

At 1 January
2024

£
Materials
-
HCP
-
Webinars
-
Bursaries for events
6,319
Pop-up events
-
Train-the-trainer
-
6,319		 Incoming
resources
£
500
19,475
9,500
-
3,850
16,250
49,575		 Resources
expended
£
(391)
(19,475)
(9,500)
(2,400)
(3,404)
-
(35,170)		 Transfers
£
-
-
-
-
(446)
-
(446)		 At 31
December
2024
£
109
-
-
3,919
-
16,250
20,278

33

OVERCOMING MULTIPLE SCLEROSIS NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

Fund descriptions:

Materials – equipment to be used at pop-up events

HCP – to develop engagement with health care professionals

Webinars – to fund online interactive presentations

Bursaries – to provide financial assistance for qualifying attendees at retreats. Pop-up events – local community events

Train the trainer – to provide education, material and support to facilitators

Previous year: At 1 January Incoming Resources Transfers At 31
2023 resources expended December
2023
£ £ £ £ £
Gawler books 6,741 - - (6,741) -
Bursaries for events 7,000 - (681) - 6,319
Trustee recruitment 6,000 11,400 (17,400) - -
19,741 11,400 (18,081) (6,741) 6,319

Fund descriptions:

The Gawler books donation was to fund Overcoming MS books delivered to the Gawler foundation in Australia. This restriction has now been removed and the balance transferred to unrestricted reserves. Bursaries – to provide financial assistance for qualifying attendees at retreats. Trustee recruitment was to fund Trustee recruitment.

21. Analysis of net assets between funds

nalysis of net assets between funds
Unrestricte
d funds
general
Unrestricted
funds
designated
reserves
2024
2024
At 31 December 2024:
£
£
Intangible fixed assets
34,642
-
Tangible assets
10,101
-
Current assets/(liabilities)
350,941
90,000
395,684
90,000
Unrestricte
d funds
general
Unrestricted
funds
designated
reserves
2023
2023
At 31 December 2023:
£
£
Intangible fixed assets
11,100
-
Tangible assets
12,523
-
Current assets/(liabilities)
254,680
-
278,303
-		 Restricted
funds
2024
£
-
-
20,278
20,278
Restricted
funds
2023
£
-
-
6,319
6,319		 Total
2024
£
34,642
10,101
461,219
505,962
Total
2023
£
11,100
12,523
260,999
284,622

34

OVERCOMING MULTIPLE SCLEROSIS NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

22. Related party transactions

In the year pro bono legal advice valued at £20,000 (2023: £5,000) was received from a company in which one of the Trustees is a shareholder.

Aggregate unrestricted donations of £1,200 (2023: £1,200) were received from related parties.

23. Analysis of changes in net funds

The Charity had no material debt during the year.

24. Cash generated from operations

ash generated from operations
Surplus/(deficit) for the year
Adjustments for:
Investment income recognised in statement of financial activities
Amortisation and impairment of intangible assets
Depreciation and impairment of tangible fixed assets
Movements in working capital:
(Increase)/decrease in stocks
(Increase)/decrease in debtors
(Decrease) in creditors
Increase/(decrease) in deferred income
Cash generated from operations		 2024
£
221,340
(4,510)
5,570
3,320
-
(42,426)
(32,612)
21,011
171,593		 2023
£
(32,479)
(3,015)
-
3,556
4,533
108,209
(1,219)
(1,316)
78,269

35